Carol Greider: The Christmas Day Discovery of Telomerase
Sunny Youn, Research Fellow at Product Manager Accelerator, shared a post on LinkedIn:
“Re-posting this article about some breakthroughs in science by unsung women heros…I mean, heroines
In the early 1980s, scientists Elizabeth Blackburn and Jack Szostak discovered that some cells could maintain their telomeres—protective DNA caps on chromosomes—without shortening, suggesting the existence of an unknown enzyme that rebuilt them. In 1984, 23-year old graduate student Carol Greider joined Blackburn’s lab at UC Berkeley to find that enzyme.
After nine months of failed experiments using Tetrahymena (a pond organism rich in telomeres), Greider ran one more test on Christmas Day, 1984, and finally saw proof: a faint DNA pattern showing telomere extension. She had discovered telomerase, the enzyme that maintains telomere length.
Following months of confirmation, Greider and Blackburn published their findings in 1985—initially overlooked because the work used “pond scum.” Later research proved telomerase existed in humans and was key to cell aging and cancer, as it enables cancer cells to divide indefinitely.
Greider earned her PhD, led her own lab, and continued groundbreaking telomere research. In 2009, she, Blackburn, and Szostak received the Nobel Prize in Physiology or Medicine for their discovery.
Her story illustrates how major breakthroughs often arise from curiosity, persistence, and patience—not grand plans. The discovery of telomerase transformed science across fields like aging, cancer biology, degenerative disease, and longevity research—all tracing back to one determined graduate student working alone on Christmas morning.”
Stay updated with Hemostasis Today.
-
Oct 16, 2026, 13:10Emanuel Sueldo: CAHT 2026 Celebrates Scientific Progress and Team Achievements
-
Oct 16, 2026, 13:05Maha Othman: Queen’s Health Sciences Advances CAT Risk Models and Pediatric ISTH-BAT Cut-Offs
-
Oct 16, 2026, 13:03Thrombosis Awareness Must Lead to Timely Action – Roche
-
Oct 16, 2026, 12:49Wolfgang Miesbach: 5-Year CBDR Data Confirms Emicizumab Safety and Efficacy in Hemophilia A
-
Oct 16, 2026, 12:40Edward Lee Carter: How Factor XI Inhibition Could Transform Anticoagulation Therapy
-
Oct 16, 2026, 12:40Marc Carrier: Looking Ahead to ISTH 2027 in Vancouver
-
Oct 16, 2026, 12:30Bob Lempke: How One Blood Donation Can Save Up to Three Lives
-
Oct 16, 2026, 12:30Why VWF Therapies Belong on the EU Critical Medicines List – EHC
-
Oct 16, 2026, 12:17Exploring Endothelial Cells, Genetic Fate Mapping, and Revascularization – ISTH